MBX | MBX BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$55.00
+$0.60 (+1.10%)

MBX Biosciences (MBX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.

The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $55.00 vs 50 $57.35 / 200 $45.72
Projection
No cross projected
Test
No active test
Last cross
Golden cross 28 Aug 2025 ยท projected 19 bars out ยท tested 2 bars

Weekly

No weekly data

4-hour as of 3 Nov 16:00 ET

Price
between the two $55.00 vs 50 $53.48 / 200 $58.25
Projection
No cross projected
Test
No active test
Last cross
Death cross 20 Oct 2026 bar 2 ยท projected 27 bars out ยท tested 1 bar

Cross history

2
crosses on record since 2025
1 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 Oct 2026Death4-hour27 bars out1 bar cross test
28 Aug 2025Golden flatdaily19 bars out2 bar cross test

About MBX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$27.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.